psilocybin

Researchers at the University of California, San Diego report that people with depression who use psilocybin do not abandon conventional mental health care, contrary to fears that psychedelic use might delay or replace standard treatment. The findings suggest psilocybin users continue to seek professional help, easing concerns among clinicians as interest in psychedelic therapies for depression grows.

A state health department has held a hearing on patient access to medical psilocybin, collecting concerns from stakeholders about how the psychedelic treatment can be obtained. Testimony focused on barriers to access and the regulatory framework. The debate reflects a broader national push, following Oregon and Colorado, to legalise psilocybin for therapeutic use in conditions such as depression and PTSD.